Skip to main content
. 2016 Oct 7;40(2):126–131. doi: 10.1002/clc.22596

Figure 1.

Figure 1

Ethnic differences in the incidence of stroke or systemic embolism and major bleeding.5, 6, 7 (A) Incidence of stroke or systemic embolism in Asian populations. (B) Incidence of stroke or systemic embolism in Non‐Asian populations. (C) Incidence of major bleeding in Asian populations. (D) Incidence of major bleeding in Non‐Asian populations. Abbreviations: ARISTOTLE, Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; bid, twice a day; D110, dabigatran 110 mg bid; D150/R20/A5, dabigatran 150 mg bid/rivaroxaban 20 mg qd/apixaban 5 mg bid; qd, once a day; RE‐LY, Randomized Evaluation of Long‐term Anticoagulation Therapy; ROCKET AF, Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation.